Skip to main content

Advertisement

Figure 2 | Journal for ImmunoTherapy of Cancer

Figure 2

From: T cell-NF-κB activation is required for tumor control in vivo

Figure 2

Normal T cell priming in CD4-cre x IKKβ fl/fl mice. CD4-cre x IKKβfl/fl mice were subcutaneously injected with 106 MC57-SIY tumor cells, were sacrificed on day 7 and splenocytes were prepared for flow cytometry. Graphical representation (a and c) and absolute numbers (b and d) of SYI:Kb+ tumor-specific CD8+ T cells (a and b) and of Ki67+ proliferating CD8+CD44hi cells (c and d). Results are representative of at least 2 independent experiments. NS = not significant.

Back to article page